Home Medicine Novel PIK3R1 gene mutation associated with SHORT syndrome: a case report of a 15-year-old female
Article
Licensed
Unlicensed Requires Authentication

Novel PIK3R1 gene mutation associated with SHORT syndrome: a case report of a 15-year-old female

  • Amani Osman , Amr Morsi ORCID logo EMAIL logo , Sherif El-Refee and Sara Suliman
Published/Copyright: September 12, 2024

Abstract

Objectives

To present the clinical journey and management of a 15-year-old female with SHORT syndrome, highlighting the diagnostic challenges and the novel genetic mutation identified.

Case presentation

A 15-year-old Filipino female was initially seen in a dermatology clinic at 9 years old for axillary skin darkening, indicative of acanthosis nigricans. Early evaluations revealed elevated blood glucose levels, resulting in a pediatric diabetes diagnosis without the usual hyperglycemic symptoms. Her medical history was notable for premature birth, intrauterine growth restriction, a cardiac murmur from patent ductus arteriosus and a bicuspid aortic valve, delayed teething, and distinct dysmorphic features. Genetic testing identified a novel PIK3R1 gene mutation. Treatment with metformin significantly improved her glycemic control and lipid profiles. The patient also displayed delayed puberty and polycystic ovary syndrome-like symptoms, but growth hormone deficiency was excluded. Endocrine evaluation for her short stature and lipodystrophy confirmed the presence of the PIK3R1 mutation.

Conclusions

This case highlights the importance of thorough endocrine and genetic evaluations in patients with complex clinical presentations like SHORT syndrome. The identification of a novel PIK3R1 gene mutation expands the understanding of the genetic basis of this syndrome and underscores the need for individualized treatment approaches.


Corresponding author: Amr Morsi, Consultant Pediatric Endocrinologist, Imperial College London Diabetes Centre, Abu Dhabi, United Arab Emirates, E-mail:
Sara Suliman as senior author.
  1. Research ethics: The local Institutional Review Board deemed the study exempt from review.

  2. Informed consent: Informed consent was obtained from all individuals included in this study. Informed consent available upon request.

  3. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  4. Use of Large Language Models, AI and Machine Learning Tools: Not applicable.

  5. Competing interests: Authors state no conflict of interest.

  6. Research funding: None declared.

  7. Data availability: Not applicable.

References

1. Ogawa, W, Araki, E, Ishigaki, Y, Hirota, Y, Maegawa, H, Yamauchi, T, et al.. New classification and diagnostic criteria for insulin resistance syndrome. Diabetol Int 2022;13:337–43. https://doi.org/10.1007/s13340-022-00570-5.Search in Google Scholar PubMed PubMed Central

2. Thauvin-Robinet, C, Auclair, M, Duplomb, L, Caron-Debarle, M, Avila, M, St-Onge, J, et al.. PIK3R1 mutations cause syndromic insulin resistance with lipoatrophy. Am J Hum Genet 2013;93:141–9. https://doi.org/10.1016/j.ajhg.2013.05.019.Search in Google Scholar PubMed PubMed Central

3. Solheim, MH, Clermont, AC, Winnay, JN, Hallstensen, E, Molven, A, Njølstad, PR, et al.. Iris malformation and anterior segment dysgenesis in mice and humans with a mutation in PI 3-kinase. Invest Ophthalmol Vis Sci 2017;58:3100–6. https://doi.org/10.1167/iovs.16-21347.Search in Google Scholar PubMed PubMed Central

4. Mubeen, S, Gibson, C, Mubeen, R, Mansour, S, Evans, RD. SHORT syndrome: systematic appraisal of the medical and dental phenotype. Cleft Palate-Craniofac J 2022;59:873–81. https://doi.org/10.1177/10556656211026859.Search in Google Scholar PubMed

5. Shvalb, NF. SHORT syndrome: an update on pathogenesis and clinical spectrum. Curr Diab Rep 2022;22:571–7. https://doi.org/10.1007/s11892-022-01495-8.Search in Google Scholar PubMed

6. Lee, CL, Chuang, CK, Chiu, HC, Tu, RY, Lo, YT, Chang, YH, et al.. The first SHORT syndrome in a Taiwanese boy: a case report and review of the literature. Mol Genet Metab Rep 2021;27:100768. https://doi.org/10.1016/j.ymgmr.2021.100768.Search in Google Scholar PubMed PubMed Central

7. Kwok, A, Zvetkova, I, Virtue, S, Luijten, I, Huang-Doran, I, Tomlinson, P, et al.. Truncation of Pik3r1 causes severe insulin resistance uncoupled from obesity and dyslipidaemia by increased energy expenditure. Mol Metab 2020;40:101020. https://doi.org/10.1016/j.molmet.2020.101020.Search in Google Scholar PubMed PubMed Central

8. Kim, SH, Kim, M, Yim, J, Kim, M, Jang, DH. Transient neonatal diabetes mellitus in SHORT syndrome: a case report. Front Pediatr 2021;9:650920. https://doi.org/10.3389/fped.2021.650920.Search in Google Scholar PubMed PubMed Central

9. Patel, V, Cui, W, Cobben, JM. SHORT syndrome with microcephaly and developmental delay. Am J Med Genet A 2023;191:850–4. https://doi.org/10.1002/ajmg.a.63078.Search in Google Scholar PubMed

10. Salinas-Torres, VM, De La O-Expinoza, EA, Salinas-Torres, RA. Expansion of the short syndrome phenotype in an adult patient with unilateral basal ganglia calcification. Genet Couns 2016;27:479–83.Search in Google Scholar

11. Singh, A, Arora, R, Singh, P, Kapoor, S. Short syndrome-an expanding phenotype. Indian Pediatr 2013;50:414–6. https://doi.org/10.1007/s13312-013-0099-8.Search in Google Scholar PubMed

12. Reardon, W, Temple, IK. Nephrocalcinosis and disordered calcium metabolism in two children with SHORT syndrome. Am J Med Genet A 2008;146:1296–8. https://doi.org/10.1002/ajmg.a.32250.Search in Google Scholar

13. Sorge, G, Ruggieri, M, Polizzi, A, Scuderi, A, Di Pietro, M. SHORT syndrome: a new case with probable autosomal dominant inheritance. Am J Med Genet 1996;61:178–81. https://doi.org/10.1002/(sici)1096-8628(19960111)61:2<178::aid-ajmg16>3.3.co;2-6.10.1002/(SICI)1096-8628(19960111)61:2<178::AID-AJMG16>3.3.CO;2-6Search in Google Scholar

14. Sun, L, Zhang, Q, Li, Q, Tang, Y, Wang, Y, Li, X, et al.. A novel PIK3R1 mutation of SHORT syndrome in a Chinese female with diffuse thyroid disease: a case report and review of literature. BMC Med Genet 2020;21:215. https://doi.org/10.1186/s12881-020-01146-3.Search in Google Scholar

15. Szczawińska-Popłonyk, A, Bernat-Sitarz, K, Schwartzmann, E, Piechota, M, Badura-Stronka, M. Clinical and immunological assessment of APDS2 with features of the SHORT syndrome related to a novel mutation in PIK3R1 with reduced penetrance. Allergol Immunopathol 2022;50:1–9. https://doi.org/10.15586/aei.v50i4.510.Search in Google Scholar

Received: 2024-05-21
Accepted: 2024-08-29
Published Online: 2024-09-12
Published in Print: 2024-12-17

© 2024 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Review
  3. Effect and safety of aromatase inhibitors for the treatment of short stature in male children and adolescents: a meta-analysis of randomized controlled trials
  4. Original Articles
  5. Do hybrid closed loop insulin pump systems improve glycemic control and reduce hospitalizations in poorly controlled type 1 diabetes?
  6. Long-term effectiveness and safety of long-acting growth hormone preparation in children with growth hormone deficiency
  7. Gonadal changes in children and adolescents with congenital adrenal hyperplasia
  8. Hsa_circ_0002473 inhibits GH3 cell proliferation and GH secretion as a competitive endogenous RNA for has-miR-4645-3p
  9. Through the eyes of the parents: a transdiagnostic psychiatric perspective for children with differences of sexual development
  10. Experiences and psychological issues affecting parents of children born with atypical genitalia in India
  11. Case Reports
  12. A rare case of central precocious puberty in a male infant with adrenal hypoplasia congenita
  13. Gly183Ser homozygous mutation of the steroid 5-a reductase type 2 (SRD5A2) gene in a Brazilian patient: case report
  14. Novel PIK3R1 gene mutation associated with SHORT syndrome: a case report of a 15-year-old female
  15. Mineralocorticoid receptor antagonist monotherapy in pediatric non-classical 11β-hydroxylase deficiency
  16. A rare case of skeletal dysplasia: biallelic variant in ACAN gene
  17. Letter to the Editor
  18. Another look at the necessity of polysomnography for infants with Prader-Willi syndrome prior to initiation of growth hormone therapy
  19. Annual Reviewer Acknowledgment
  20. Reviewer Acknowledgment
Downloaded on 5.1.2026 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2024-0244/html
Scroll to top button